Maintenance therapy in acute myeloid leukemia: advances and controversies

The last decade has seen steadfast progress in drug development in acute myeloid leukemia (AML) which has moved progressively towards genomic-based therapy. With these advances, outcomes in AML have improved but remains far from satisfactory. One approach towards preventing relapse in AML is to use...

Descripción completa

Detalles Bibliográficos
Autores principales: Senapati, Jayastu, Kadia, Tapan M., Ravandi, Farhad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483353/
https://www.ncbi.nlm.nih.gov/pubmed/37139599
http://dx.doi.org/10.3324/haematol.2022.281810

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483353/
https://www.ncbi.nlm.nih.gov/pubmed/37139599
http://dx.doi.org/10.3324/haematol.2022.281810

Ejemplares similares